Kaneka’s ubiquinol supplement helps French nurses fight fatigue during pandemic, trial finds
A survey and trial conducted by French healthcare market research company Expansion Consulteam found that nurses working during the COVID-19 pandemic who took a ubiquinol supplement daily felt less tired and stressed.
Photo © Anna Shvets/Pexels.com
A survey and trial conducted by French healthcare market research company Expansion Consulteam found that nurses working during the COVID-19 pandemic who took a ubiquinol supplement daily felt less tired and stressed.
During the pandemic, 85 unvaccinated French nurses were asked to supplement with 100 mg daily of ubiquinol for 60 days. The supplement contained Ubiquinol, a trademarked ubiquinol ingredient from supplier Kaneka Nutrients Europe (Zaventem, Belgium). Ubiquinol is the active form of coenzyme Q10 that supports the body’s own natural supply and helps cells produce energy.
Half of the supplemented nurses worked in hospitals, and half worked in private practice. Prior to the trial, most participants reported experiencing “stress, tiredness, and mental exhaustion.” At the end of the 60 days of supplementation, 62% of participants reported feeling less stressed, 55% said they felt less physically fatigued, and 56% said they felt less mentally fatigued, compared to before supplementation started. Improvements on average were reported to occur 24 days after the trial’s start.
The news was reported by Kaneka. In a Kaneka press release, Filip Van hulle, general manager, Kaneka Nutrients Europe, stated, “Many consumers are currently looking to improve their overall health, and ubiquinol could well be the solution. It supports several areas simultaneously, such as heart health, immunity, and mental well-being, and contributes to improved energy and endurance.”
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.
Judge denies CRN’s motion for preliminary injunction but its lawsuit against NY state will proceed
April 23rd 2024The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.
Arla Foods to acquired whey nutrition business from Volac International
April 22nd 2024Arla Foods Ingredients has reached an agreement to acquire Volac’s Whey Nutrition business through a purchase of shares in Volac Whey Nutrition Holdings Limited and its subsidiary, Volac Whey Nutrition Limited and Volac Renewable Energy Limited.
CRN NY State lawsuit update: Dispatch from SupplySide East 2024
April 18th 2024CRN's Steve Mister updates Nutritional Outlook about its ongoing litigation against NY State. The organization sued the state to prevent the enforcement of law that bans sale of weight management supplements to minors.
